Jiang M, Aittomäki K, Nilsson C, Pakarinen P, Iitiä A, Torresani T, Simonsen H, Goh V, Pettersson K, de la Chapelle A, Huhtaniemi I
Department of Physiology, University of Turku, Finland.
J Clin Endocrinol Metab. 1998 Dec;83(12):4338-43. doi: 10.1210/jcem.83.12.5306.
We have described previously in the Finnish population an inactivating point mutation (566C-->T) in the human FSH receptor (FSHR) gene. In women, this mutation causes hypergonadotropic ovarian failure with arrest of follicular maturation and infertility, whereas in men, there is variable suppression of spermatogenesis, but no absolute infertility. To determine whether the same FSHR mutation occurs in other populations, its frequency was determined in Finland, Switzerland, Denmark, and the Chinese population of Singapore. The mutation was screened for using genomic DNA extracted from whole blood or dried blood spots. Exon 7 of the FSHR gene was first amplified using a pair of biotinylated primers. The PCR products were then immobilized on streptavidin-coated microtitration wells and hybridized using short allele-specific oligonucleotide probes labeled with europium. Time-resolved fluorometry was used for europium signal detection. To test the reliability of this method, 40 isolated DNA samples and 35 dried blood spot samples were blindly tested for the 566C-->T FSHR mutation. The analyses yielded identical results with denaturing gradient gel electrophoresis and allele-specific restriction enzyme digestion of the same samples, thus demonstrating the reliability of the tested method. Automation of this procedure allows the screening of large numbers of samples, which was subsequently carried out to investigate the frequency of the 566C-->T mutation in the study populations. A total of 4981 samples from the above-mentioned 4 countries were analyzed. The frequency of the 566C-->T mutation was 0.96% for all Finnish samples (n=1976), with a strong enrichment of the mutant allele in the northeastern part of the country. Only 1 mutation carrier was identified in the samples from Switzerland (n=1162), whereas none was found in samples from Denmark (n=1094) and the Singapore Chinese (n=540). These results suggest that the 566C-->T mutation of the FSHR gene is enriched in Finland, but is uncommon in other populations.
我们之前在芬兰人群中描述了人类促卵泡激素受体(FSHR)基因中的一种失活点突变(566C→T)。在女性中,这种突变会导致高促性腺激素性卵巢功能衰竭,卵泡成熟受阻并导致不孕,而在男性中,精子发生受到不同程度的抑制,但并非绝对不育。为了确定其他人群中是否存在相同的FSHR突变,我们在芬兰、瑞士、丹麦以及新加坡的华裔人群中测定了其频率。使用从全血或干血斑中提取的基因组DNA对该突变进行筛查。首先使用一对生物素化引物扩增FSHR基因的第7外显子。然后将PCR产物固定在包被链霉亲和素的微量滴定孔上,并使用标记有铕的短等位基因特异性寡核苷酸探针进行杂交。时间分辨荧光法用于检测铕信号。为了测试该方法的可靠性,对40个分离的DNA样本和35个干血斑样本进行了566C→T FSHR突变的盲测。分析结果与相同样本的变性梯度凝胶电泳和等位基因特异性限制性酶切结果一致,从而证明了所测试方法的可靠性。该程序的自动化使得能够筛查大量样本,随后对研究人群中566C→T突变的频率进行了调查。共分析了上述4个国家的4981个样本。所有芬兰样本(n = 1976)中566C→T突变的频率为0.96%,该突变等位基因在该国东北部高度富集。在瑞士的样本(n = 1162)中仅鉴定出1名突变携带者,而在丹麦的样本(n = 1094)和新加坡华裔的样本(n = 540)中均未发现突变携带者。这些结果表明,FSHR基因的566C→T突变在芬兰富集,但在其他人群中并不常见。